TrumpRx.gov: Pharma CEOs Announce Lower Drug Prices & US Manufacturing

Launch of TrumpRx.gov Initiative

• 💡 President Trump convened top pharmaceutical executives to launch TrumpRx.gov, a new federal initiative aimed at reducing prescription drug prices and improving patient access.
• ✅ The event highlighted a collaborative effort between the administration and industry to enhance health security and ensure affordability for American patients.

GSK's Commitment to Lowering Costs

• 🎯 GSK announced a significant commitment to lower the cost of medicines for 40 million Americans living with asthma or COPD.
• 💊 This includes offering deep discounts on eight core medicines through direct channels and donating ingredients for rescue inhalers to improve access.
• 💰 GSK is also investing $30 billion in American manufacturing, research, technology, and talent to support US health security.

Merck and Novartis Contributions

• 🔬 Merck expressed support for TrumpRx.gov, highlighting a novel oral cardiovascular drug designed to significantly lower LDL and address cardiovascular disease, making it affordable and easy to get.
• 🏭 Novartis committed to scaling manufacturing in the United States, planning to build nine new facilities to ensure critical medicines, including advanced technologies like radioligand and cell/gene therapies, are made domestically for US patients.

Sanofi's Focus on Patient Affordability

• 🤝 Sanofi reaffirmed its unwavering commitment to patients, stating that affordability has been at the heart of their mission for a long time.
• 📈 The company believes the collaboration with the administration allows them to go further in improving affordability while preserving innovation.

Collaborative Progress for Patients

• 👏 The initiative demonstrates that when industry and government collaborate with the spirit of doing the right thing for patients, significant progress can be achieved.
• 🇺🇸 The overall goal is to drive affordability and access for Americans, with a focus on ensuring patients can obtain necessary medications without financial struggle.